Related references
Note: Only part of the references are listed.Multidisciplinary Consensus for the Management of Pulmonary Thromboembolism
Jose Luis Lobo et al.
ARCHIVOS DE BRONCONEUMOLOGIA (2022)
Extended anticoagulation treatment for cancer-associated thrombosis-Rates of recurrence and bleeding beyond 6 months: A systematic review
Florian Moik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Venous Thromboembolism and Cancer: A Comprehensive Review from Pathophysiology to Novel Treatment
Mario Enrico Canonico et al.
BIOMOLECULES (2022)
Subgroup analysis in randomized controlled trials: Useful or misleading?
Tobias Tritschler et al.
THROMBOSIS RESEARCH (2022)
American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer
Gary H. Lyman et al.
BLOOD ADVANCES (2021)
Moving forward for incidental pulmonary embolism in cancer patients
Caio Julio Cesar dos Santos Fernandes et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: A systematic review and meta-analysis
Lucia Caiano et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Nigel S. Key et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomization of the SELECT-D Trial (SELECT-D: 12m)
Andrea Marshall et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A Case-Control Analysis of the Impact of Venous Thromboembolic Disease on Quality of Life of Patients with Cancer: Quality of Life in Cancer (Qca) Study
Lucia Marin-Barrera et al.
CANCERS (2020)
A snapshot of cancer-associated thromboembolic disease in 2018-2019: First data from the TESEO prospective registry
Alberto Carmona-Bayonas et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2020)
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Treatment and Long-Term Clinical Outcomes of Incidental Pulmonary Embolism in Patients With Cancer: An International Prospective Cohort Study
Noémie Kraaijpoel et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post-hoc analysis of the Hokusai-VTE Cancer study
Marcello Di Nisio et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer
Dominique Farge et al.
LANCET ONCOLOGY (2019)
Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function
Lucia Mazzolai et al.
EUROPEAN HEART JOURNAL (2018)
Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)
Annie M. Young et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
Gary E. Raskob et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
D-dimer and high-sensitivity C-reactive protein levels to predict venous thromboembolism recurrence after discontinuation of anticoagulation for cancer-associated thrombosis
Luis Jara-Palomares et al.
BRITISH JOURNAL OF CANCER (2018)
Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Carme Font et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Tinzaparin in cancer associated thrombosis beyond 6 months: TiCAT study
Luis Jara-Palomares et al.
THROMBOSIS RESEARCH (2017)
Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH
S. Kaatz et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Management of unsuspected pulmonary embolism in cancer patients
Javier Trujillo-Santos et al.
EXPERT REVIEW OF HEMATOLOGY (2013)
Unsuspected pulmonary embolism in lung cancer patients: Comparison of clinical characteristics and outcome with suspected pulmonary embolism
Atul B. Shinagare et al.
LUNG CANCER (2012)
Risk of Recurrent Venous Thromboembolism and Mortality in Patients With Cancer Incidentally Diagnosed With Pulmonary Embolism: A Comparison With Symptomatic Patients
Paul L. den Exter et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Unsuspected Pulmonary Emboli in Oncology Patients Undergoing Routine Computed Tomography Imaging
Ann Michelle Browne et al.
JOURNAL OF THORACIC ONCOLOGY (2010)
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis
F. Dentali et al.
THROMBOSIS RESEARCH (2010)
Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy
A. A. Khorana et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry
M. Monreal et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Incidental pulmonary emboli in oncology patients: Prevalence, CT evaluation, and natural history
Gregory W. Gladish et al.
RADIOLOGY (2006)
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
P Prandoni et al.
BLOOD (2002)
Share Paper
